Geron Corporation

GERN

$1.13

Name : Geron Corporation

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $721,341,440.00

EPSttm : -0.12

Geron Corporation

$1.13

0.89%

$0.01

Float Short %

14.12

Margin Of Safety %

Put/Call OI Ratio

0.11

EPS Next Q Diff

0.01

EPS Last/This Y

0.15

EPS This/Next Y

0.08

Price

1.13

Target Price

3.6

Analyst Recom

Performance Q

-20.98

Relative Volume

0.98

Beta

0.58

Ticker: GERN

21 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-10-20	GERN	1.27	0.05	0.06	83182
2025-10-21	GERN	1.275	0.05	0.02	83769
2025-10-22	GERN	1.23	0.05	0.07	84000
2025-10-23	GERN	1.225	0.05	0.01	84116
2025-10-24	GERN	1.23	0.05	0.07	86712
2025-10-27	GERN	1.27	0.05	0.00	87324
2025-10-28	GERN	1.275	0.05	0.00	88392
2025-10-29	GERN	1.235	0.05	0.00	88906
2025-10-30	GERN	1.235	0.05	0.00	89019
2025-10-31	GERN	1.26	0.05	0.00	89084
2025-11-03	GERN	1.2	0.05	0.01	89114
2025-11-04	GERN	1.145	0.05	0.00	89533
2025-11-05	GERN	1.09	0.05	0.06	90067
2025-11-06	GERN	1.075	0.05	0.03	93096
2025-11-07	GERN	1.075	0.05	0.05	93081
2025-11-10	GERN	1.165	0.05	3.47	93136
2025-11-11	GERN	1.255	0.06	0.00	94329
2025-11-12	GERN	1.245	0.06	0.16	94403
2025-11-13	GERN	1.15	0.06	0.47	94309
2025-11-14	GERN	1.12	0.06	16.95	95867
2025-11-17	GERN	1.135	0.11	7.81	100004
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

21 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-10-20	GERN	1.27	8.3	42.1	-0.12
2025-10-21	GERN	1.27	8.3	43.5	-0.12
2025-10-22	GERN	1.24	8.3	44.1	-0.12
2025-10-23	GERN	1.23	8.3	43.7	-0.12
2025-10-24	GERN	1.23	8.3	43.3	-0.12
2025-10-27	GERN	1.27	8.3	43.0	-0.12
2025-10-28	GERN	1.28	8.3	43.7	-0.12
2025-10-29	GERN	1.23	8.3	44.5	-0.12
2025-10-30	GERN	1.24	8.3	43.5	-0.12
2025-10-31	GERN	1.26	8.3	43.2	-0.12
2025-11-03	GERN	1.20	8.3	44.7	-0.12
2025-11-04	GERN	1.14	8.3	44.8	-0.13
2025-11-05	GERN	1.09	8.3	44.8	-0.13
2025-11-06	GERN	1.08	8.3	43.9	-0.13
2025-11-07	GERN	1.07	0.8	43.8	-0.13
2025-11-10	GERN	1.16	0.8	-10.0	-0.13
2025-11-11	GERN	1.25	0.8	-22.7	-0.14
2025-11-12	GERN	1.25	0.8	-15.4	-0.14
2025-11-13	GERN	1.15	0.8	-8.8	-0.14
2025-11-14	GERN	1.12	-12.4	-12.9	-0.14
2025-11-17	GERN	1.13	15.7	-17.5	-0.12
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-10-20	GERN	0.04	0.06	14.85
2025-10-21	GERN	0.04	0.06	14.85
2025-10-22	GERN	0.04	0.06	14.85
2025-10-23	GERN	0.04	0.06	14.85
2025-10-24	GERN	0.04	0.06	14.85
2025-10-27	GERN	0.04	0.04	14.38
2025-10-28	GERN	0.04	0.04	14.38
2025-10-29	GERN	0.04	0.04	14.38
2025-10-30	GERN	0.04	0.04	14.38
2025-10-31	GERN	0.04	0.04	14.38
2025-11-03	GERN	0.04	0.07	14.38
2025-11-04	GERN	0.04	0.07	14.38
2025-11-05	GERN	0.04	0.07	14.38
2025-11-06	GERN	0.04	0.07	14.38
2025-11-07	GERN	0.04	0.07	14.38
2025-11-10	GERN	0.04	-0.25	14.38
2025-11-11	GERN	0.04	-0.25	14.38
2025-11-12	GERN	0.04	-0.25	14.10
2025-11-13	GERN	0.04	-0.25	14.10
2025-11-14	GERN	0.00	-0.25	14.06
2025-11-17	GERN	0.00	0.58	14.12
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

-0.03

Avg. EPS Est. Current Quarter

-0.03

Avg. EPS Est. Next Quarter

-0.02

Insider Transactions

Institutional Transactions

0.58

Beta

0.58

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

78.8

Max Drawdown 5-Year %

-78.9

Target Price

3.6

P/E

Forward P/E

PEG

P/S

3.93

P/B

2.9

P/Free Cash Flow

EPS

-0.12

Average EPS Est. Cur. Y

-0.12

EPS Next Y. (Est.)

-0.04

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-43.61

Relative Volume

0.98

Return on Equity vs Sector %

-59.1

Return on Equity vs Industry %

-44.2

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

-17.5

Geron Corporation

Sector: Healthcare

Industry: Biotechnology

Employees: 229

Geron Corporation, a commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology. It offers RYTELO a telomerase inhibitor for the treatment f adult patients with low- to intermediate-1 risk myelodysplastic syndromes with transfusion-dependent anemia. The company was incorporated in 1990 and is headquartered in Foster City, California.

stock quote shares GERN – Geron Corporation Stock Price stock today

news today GERN – Geron Corporation stock forecast ,stock prediction 2023 2024 2025

marketwatch GERN – Geron Corporation yahoo finance google finance

stock history GERN – Geron Corporation invest stock market

stock prices GERN premarket after hours

ticker GERN fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: GERN

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y